Citations (57)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Maria Paz Garcia-Portilla, Adolfo Benito Ruiz, Felisa Gómez Robina, Marta García Dorado & Paola María López Rengel. (2022) Impact on functionality of the paliperidone palmitate three-month formulation in patients with a recent diagnosis of schizophrenia: a real-world observational prospective study. Expert Opinion on Pharmacotherapy 23:5, pages 629-638.
Read now
Read now
Rahul Dhanda, Della Varghese, Vijay R Nadipelli, Maurizio Fava, Namita Joshi, Caitlyn T Solem, James A Graham, Susan M Learned & Christian Heidbreder. (2019) Patient-reported outcomes in schizophrenia patients treated with once-monthly extended-release risperidone in a long-term clinical study. Patient Preference and Adherence 13, pages 1037-1050.
Read now
Read now
Cristina Domenech, Adriana Pastore, A Carlo Altamura, Corrado Bernasconi, Ricardo Corral, Helio Elkis, Jonathan Evans, Ashok Malla, Francesco Margari, Marie-Odile Krebs, Anna-Lena Nordstroem, Mathias Zink & Josep Maria Haro. (2019) Correlation of Health-Related Quality of Life in Clinically Stable Outpatients with Schizophrenia. Neuropsychiatric Disease and Treatment 15, pages 3475-3486.
Read now
Read now
Wenyu Ye, Shinji Fujikoshi, Naohiro Nakahara, Michihiro Takahashi, Haya Ascher-Svanum & Tetsuro Ohmori. (2012) One-year outcomes in schizophrenia after switching from typical antipsychotics to olanzapine in Japan: an observational study. Pragmatic and Observational Research 3, pages 41-49.
Read now
Read now
Anneli Pitkänen, Maritta Välimäki, Jean Endicott, Jouko Katajisto, Tiina Luukkaala, Marita Koivunen, Lauri Kuosmanen & Heli Hätönen. (2012) Assessing quality of life in patients with schizophrenia in an acute psychiatric setting: Reliability, validity and feasibility of the EQ-5D and the Q-LES-Q. Nordic Journal of Psychiatry 66:1, pages 19-25.
Read now
Read now
María Fe Bravo-Ortiz, José Ramón Gutiérrez-Casares, Alexander Rodríguez-Morales, Mario Alberto Peña García & Rebeca Hidalgo-Borrajo. (2011) Influence of type of treatment on the well-being of Spanish patients with schizophrenia and their caregivers. International Journal of Psychiatry in Clinical Practice 15:4, pages 286-295.
Read now
Read now
Kara Savilla, Lisa Kettler & Cherrie Galletly. (2008) Relationships between cognitive deficits, symptoms and quality of life in schizophrenia. Australian and New Zealand Journal of Psychiatry 42:6, pages 496-504.
Read now
Read now
Julio Bobes, Maria Paz Garcia-Portilla, Maria Teresa Bascaran, Pilar Alejandra Saiz & Manuel Bouzoño. (2007) Quality of life in schizophrenic patients. Dialogues in Clinical Neuroscience 9:2, pages 215-226.
Read now
Read now
Juan M Cabasés, Eduardo Sánchez, Francisco J Vázquez-Polo, Miguel A Negrín & Emilio J Domínguez. (2005) Self-perceived health status of schizophrenic patients in Spain: analysis of geographic differences. Expert Review of Pharmacoeconomics & Outcomes Research 5:5, pages 531-540.
Read now
Read now
Jeffrey J. Ellis, Kim A. Eagle, Eva M. Kline-Rogers & Steven R. Erickson. (2005) Validation of the EQ‐5D in patients with a history of acute coronary syndrome. Current Medical Research and Opinion 21:8, pages 1209-1216.
Read now
Read now
Articles from other publishers (47)
Claudio Brasso, Silvio Bellino, Paola Bozzatello, Cristiana Montemagni, Marco Giuseppe Alberto Nobili, Rodolfo Sgro & Paola Rocca. (2023) Second Generation Long-Acting Injectable Antipsychotics in Schizophrenia: The Patient’s Subjective Quality of Life, Well-Being, and Satisfaction. Journal of Clinical Medicine 12:22, pages 6985.
Crossref
Crossref
Yanhui Li, Gurpreet Rekhi, Mei San Ang & Jimmy Lee. (2023) Impact of negative symptoms on health-related quality of life in schizophrenia. Frontiers in Psychiatry 14.
Crossref
Crossref
N. M. den Bleijker, M. M. E. van Schothorst, I. J. M. Hendriksen, W. Cahn, N. K. de Vries, P. N. van Harten & J. Deenik. (2022) Effectiveness and implementation of a multidisciplinary lifestyle focused approach in the treatment of inpatients with mental illness (MULTI +): a stepped wedge study protocol. BMC Psychiatry 22:1.
Crossref
Crossref
David Batalla-Martín, Maria-Antonia Martorell-Poveda, Angel Belzunegui-Eraso, Eva Miralles Garijo, Ana Del-Cuerpo Serratosa, JuanCarlos Valdearcos Pérez, Miquel Montané Escobar & Marina Lopez-Ruiz. (2022) The Experience of Insomnia in Patients With Schizophrenic Disorder: A Qualitative Study. Frontiers in Psychiatry 12.
Crossref
Crossref
Fredrick Dermawan Purba, Yusi Anggriani & Tri Murtini. (2021) EQ-5D-5L in Schizophrenia: differences between patients and nurses’ reports. Health and Quality of Life Outcomes 19:1.
Crossref
Crossref
G. Fond, O. Godin, F. Schürhoff, F. Berna, M. André, B. Aouizerate, D. Capdevielle, I. Chereau, T. D’ Amato, C. Dubertret, J. Dubreucq, C. Faget, C. Lançon, S. Leignier, J. Mallet, D. Misdrahi, C. Passerieux, B. Pignon, R. Rey, A. Szoke, M. Urbach, P. Vidailhet, M. Leboyer, L. Boyer & P.M. Llorca. (2020) Confirmations, advances and recommendations for the daily care of schizophrenia based on the French national FACE-SZ cohort. Progress in Neuro-Psychopharmacology and Biological Psychiatry 101, pages 109927.
Crossref
Crossref
David Batalla-Martín, Angel Belzunegui-Eraso, Eva Miralles Garijo, Elena Martínez Martín, Rosanna Romaní Garcia, Jacobo San Miguel Heras, Marina Lopez-Ruiz & Maria Antonia Martorell-Poveda. (2020) Insomnia in Schizophrenia Patients: Prevalence and Quality of Life. International Journal of Environmental Research and Public Health 17:4, pages 1350.
Crossref
Crossref
Sandeep Grover & Swapnajeet Sahoo. 2020. Schizophrenia Treatment Outcomes. Schizophrenia Treatment Outcomes
91
124
.
I.C. Chetter, A.V. Oswald, E. McGinnis, N. Stubbs, C. Arundel, H. Buckley, K. Bell, J.C. Dumville, N.A. Cullum, M.O. Soares & P. Saramago. (2019) Patients with surgical wounds healing by secondary intention: A prospective, cohort study. International Journal of Nursing Studies 89, pages 62-71.
Crossref
Crossref
Jeroen Deenik, Diederik E. Tenback, Erwin C.P.M. Tak, Ingrid J.M. Hendriksen & Peter N. van Harten. (2018) Improved psychosocial functioning and quality of life in inpatients with severe mental illness receiving a multidisciplinary lifestyle enhancing treatment. The MULTI study II. Mental Health and Physical Activity 15, pages 145-152.
Crossref
Crossref
Jeroen Deenik, Frank Kruisdijk, Diederik Tenback, Annemarie Braakman-Jansen, Erik Taal, Marijke Hopman-Rock, Aartjan Beekman, Erwin Tak, Ingrid Hendriksen & Peter van Harten. (2017) Physical activity and quality of life in long-term hospitalized patients with severe mental illness: a cross-sectional study. BMC Psychiatry 17:1.
Crossref
Crossref
John J. Isitt, Vijay R. Nadipelli, Alex Kouassi, Maurizio Fava & Christian Heidbreder. (2016) Health-related quality of life in acute schizophrenia patients treated with RBP-7000 once monthly risperidone: An 8-week, randomized, double-blind, placebo-controlled, multicenter phase 3 study. Schizophrenia Research 174:1-3, pages 126-131.
Crossref
Crossref
María Teresa Bobes-Bascarán, María Paz García-Portilla, Pilar A. Sáiz Martínez, Leticia García-Alvarez, Isabel Menéndez-Miranda, Susana Al-Halabí, María Teresa Bascarán & Julio Bobes. 2016. Beyond Assessment of Quality of Life in Schizophrenia. Beyond Assessment of Quality of Life in Schizophrenia
65
77
.
F. Schürhoff, G. Fond, F. Berna, E. Bulzacka, J. Vilain, D. Capdevielle, D. Misdrahi, M. Leboyer & P.-M. Llorca. (2015) A National Network of Schizophrenia Expert Centres: an Innovative Tool to Bridge the Research-Practice Gap. European Psychiatry 30:6, pages 728-735.
Crossref
Crossref
Rebecca L Ashby, Rhian Gabe, Shehzad Ali, Pedro Saramago, Ling-Hsiang Chuang, Una Adderley, J Martin Bland, Nicky A Cullum, Jo C Dumville, Cynthia P Iglesias, Arthur R Kang’ombe, Marta O Soares, Nikki C Stubbs & David J Torgerson. (2014) VenUS IV (Venous leg Ulcer Study IV) – compression hosiery compared with compression bandaging in the treatment of venous leg ulcers: a randomised controlled trial, mixed-treatment comparison and decision-analytic model. Health Technology Assessment 18:57, pages 1-294.
Crossref
Crossref
Aurelie Millier, Emilie Clay, Insaf Charaf, Deven Chauhan, Venkatesha Murthy, Mondher Toumi & Nadia Cadi-Soussi. (2014) Patient Reported Outcomes Instruments in Schizophrenia: A Review of Psychometric Properties. Open Journal of Medical Psychology 03:02, pages 141-156.
Crossref
Crossref
Mythily Subramaniam, Edimansyah Abdin, Lye Yin Poon, Janhavi Ajit Vaingankar, Helen Lee, Siow Ann Chong & Swapna Verma. (2014) EQ-5D as a measure of programme outcome: Results from the Singapore early psychosis intervention programme. Psychiatry Research 215:1, pages 46-51.
Crossref
Crossref
Lidia García-Pérez, Raquel Aguiar-Ibáñez, Pilar Pinilla-Domínguez, Alejandro Arvelo-Martín, Renata Linertová & Amado Rivero-Santana. (2014) Revisión sistemática de utilidades relacionadas con la salud en España: el caso de la salud mental. Gaceta Sanitaria 28:1, pages 77-83.
Crossref
Crossref
Paolo A Cortesi, Claudio Mencacci, Ferrannini Luigi, Elvezio Pirfo, Patrizia Berto, Miriam CJM Sturkenboom, Fabiana L Lopes, Maria G Giustra, Lorenzo G Mantovani & Luciana Scalone. (2013) Compliance, persistence, costs and quality of life in young patients treated with antipsychotic drugs: results from the COMETA study. BMC Psychiatry 13:1.
Crossref
Crossref
Rahul Khanna, Krutika Jariwala & John P. Bentley. (2013) Psychometric properties of the EuroQol Five Dimensional Questionnaire (EQ-5D-3L) in caregivers of autistic children. Quality of Life Research 22:10, pages 2909-2920.
Crossref
Crossref
J. Stochl, T. Croudace, J. Perez, M. Birchwood, H. Lester, M. Marshall, T. Amos, V. Sharma, D. Fowler & P. B. Jones. (2012) Usefulness of EQ-5D for evaluation of health-related quality of life in young adults with first-episode psychosis. Quality of Life Research 22:5, pages 1055-1063.
Crossref
Crossref
Li-Ren Chang, Yu-Hsuan Lin, Hung-Chieh Wu Chang, Ying-Zai Chen, Wei-Lieh Huang, Chih-Min Liu, Chen-Chung Liu & Hai-Gwo Hwu. (2013) Psychopathology, rehospitalization and quality of life among patients with schizophrenia under home care case management in Taiwan. Journal of the Formosan Medical Association 112:4, pages 208-215.
Crossref
Crossref
Li-Ren Chang, Yu-Hsuan Lin, Terry B. J. Kuo, Hung-Chieh Wu Chang, Chih-Min Liu, Chen-Chung Liu, Hai-Gwo Hwu & Cheryl C. H. Yang. (2011) Autonomic Modulation and Health-Related Quality of Life among Schizophrenic Patients Treated with Non-Intensive Case Management. PLoS ONE 6:11, pages e26378.
Crossref
Crossref
Diana Papaioannou, John Brazier & Glenys Parry. (2011) How Valid and Responsive Are Generic Health Status Measures, such as EQ-5D and SF-36, in Schizophrenia? A Systematic Review. Value in Health 14:6, pages 907-920.
Crossref
Crossref
Petri Böckerman, Edvard Johansson & Samuli I. Saarni. (2011) Do established health-related quality-of-life measures adequately capture the impact of chronic conditions on subjective well-being?. Health Policy 100:1, pages 91-95.
Crossref
Crossref
Juan M. Cabasés, Eduardo Sánchez Iriso, Joan Rovira i Forns & Javier Rejas. (2013) La calidad de vida y los costes asociados a la salud de los pacientes con trastorno de ansiedad generalizada: una aproximación bayesiana. PharmacoEconomics Spanish Research Articles 8:1, pages 3-15.
Crossref
Crossref
Haya Ascher-Svanum, Wenyu Ye, Jennifer Flynn, Shinji Fujikoshi, Naohiro Nakahara & Michihiro Takahashi. (2011) Clinical and functional outcomes for patients with schizophrenia treated with olanzapine: One-year naturalistic outcomes for inpatients and outpatients in Japan. Clinical Neuropsychopharmacology and Therapeutics 2, pages 45-55.
Crossref
Crossref
Ifigeneia Mavranezouli. (2010) A Review and Critique of Studies Reporting Utility Values for Schizophrenia-Related Health States. PharmacoEconomics 28:12, pages 1109-1121.
Crossref
Crossref
Stefan Klingberg, Andreas Wittorf, Christoph Meisner, Wolfgang Wölwer, Georg Wiedemann, Jutta Herrlich, Andreas Bechdolf, Bernhard W Müller, Gudrun Sartory, Michael Wagner, Tilo Kircher, Hans-Helmut König, Corinna Engel & Gerhard Buchkremer. (2010) Cognitive behavioural therapy versus supportive therapy for persistent positive symptoms in psychotic disorders: The POSITIVE Study, a multicenter, prospective, single-blind, randomised controlled clinical trial. Trials 11:1.
Crossref
Crossref
Tomás Sánchez-Araña Moreno, Sergio Ruiz-Doblado, José Luis Hernández-Fleta, Ramon Touriño-Gonzalez & Petra León-Pérez. (2010) Quality of life in a sample of schizophrenic patients with and without metabolic syndrome. Journal of Psychiatric Intensive Care 6:02, pages 101-108.
Crossref
Crossref
Pudtan Phanthunane, Theo Vos, Harvey Whiteford & Melanie Bertram. (2010) Health outcomes of schizophrenia in Thailand: Health care provider and patient perspectives. Asian Journal of Psychiatry 3:4, pages 200-205.
Crossref
Crossref
Samuli I. Saarni, Satu Viertiö, Jonna Perälä, Seppo Koskinen, Jouko Lönnqvist & Jaana Suvisaari. (2018) Quality of life of people with schizophrenia, bipolar disorder and other psychotic disorders. British Journal of Psychiatry 197:5, pages 386-394.
Crossref
Crossref
Takashi Nakamae, Yurinosuke Kitabayashi, Aiko Okamura, Keisuke Shibata, Sachiko Iwahashi, Fumiko Naka, Midori Morinobu, Mika Watanabe, Jin Narumoto, Masaki Kitabayashi & Kenji Fukui. (2010) Insight and quality of life in long-term hospitalized Japanese patients with chronic schizophrenia. Psychiatry and Clinical Neurosciences 64:4, pages 372-376.
Crossref
Crossref
Cecilia Adrianzén, Cesar Arango‐Dávila, Danilo Martínez Araujo, Ignacio Ruíz, Richard J. Walton, Martin Dossenbach & Jamie Karagianis. (2010)
Relative association of treatment‐emergent adverse events with quality of life of patients with schizophrenia:
post hoc
analysis from a 3‐year observational study
. Human Psychopharmacology: Clinical and Experimental 25:6, pages 439-447.
Crossref
Crossref
A.B.P. Staring, M. Van der Gaag, M. Van den Berge, H.J. Duivenvoorden & C.L. Mulder. (2009) Stigma moderates the associations of insight with depressed mood, low self-esteem, and low quality of life in patients with schizophrenia spectrum disorders. Schizophrenia Research 115:2-3, pages 363-369.
Crossref
Crossref
Malin Alenius, Margareta Hammarlund-Udenaes, Per Hartvig, Staffan Sundquist & Leif Lindström. (2009) Treatment response in psychotic patients classified according to social and clinical needs, drug side effects, and previous treatment; a method to identify functional remission. Comprehensive Psychiatry 50:5, pages 453-462.
Crossref
Crossref
A.B.P. Staring, C.L. Mulder, H.J. Duivenvoorden, L. De Haan & M. Van der Gaag. (2009) Fewer symptoms vs. more side-effects in schizophrenia? Opposing pathways between antipsychotic medication compliance and quality of life. Schizophrenia Research 113:1, pages 27-33.
Crossref
Crossref
Annemieke De Ridder & Diana De Graeve. (2009) Comparing the Cost Effectiveness of Risperidone and Olanzapine in the Treatment of Schizophrenia Using the Net-Benefit Regression Approach. PharmacoEconomics 27:1, pages 69-80.
Crossref
Crossref
David Taylor, Linda Hanssens, Jean-Yves Loze, Miranda Pans, Gilbert L'Italien & Ronald N. Marcus. (2008) Preference of medicine and patient-reported quality of life in community-treated schizophrenic patients receiving aripiprazole vs standard of care. European Psychiatry 23:5, pages 336-343.
Crossref
Crossref
Antoinette D. I. van Asselt, Carmen D. Dirksen, Arnoud Arntz, Josephine H. Giesen-Bloo, Richard van Dyck, Philip Spinhoven, Willem van Tilburg, Ismay P. Kreimers, Marjon Nadort & Johan L. Severens. (2018)
Out-patient psychotherapy for borderline personality disorder:
Cost-effectiveness of schema-focused therapy
v.
transference-focused psychotherapy
. British Journal of Psychiatry 192:6, pages 450-457.
Crossref
Crossref
John R. Hofstetter & Aimee Mayeda. 2008. Sleep and Quality of Life in Clinical Medicine. Sleep and Quality of Life in Clinical Medicine
299
311
.
Ting-Jung Chang, Yen-Huei Tarn, Ching-Lin Hsieh, Wen-Shyong Liou, James W. Shaw & Xue Grace Chiou. (2007) Taiwanese Version of the EQ-5D: Validation in a Representative Sample of the Taiwanese Population. Journal of the Formosan Medical Association 106:12, pages 1023-1031.
Crossref
Crossref
Hans-Helmut König, Christiane Roick & Matthias C. Angermeyer. (2020) Validity of the EQ-5D in assessing and valuing health status in patients with schizophrenic, schizotypal or delusional disorders. European Psychiatry 22:3, pages 177-187.
Crossref
Crossref
Hazel Hayhurst, Stephen Palmer, Rosemary Abbott, Tony Johnson & Jan Scott. (2006) Measuring health-related quality of life in bipolar disorder: Relationship of the EuroQol (EQ-5D) to condition-specific measures. Quality of Life Research 15:7, pages 1271-1280.
Crossref
Crossref
H.-H. König & S. Friemel. (2006) Gesundheitsökonomie psychischer KrankheitenEconomic evaluation of mental health care. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 49:1, pages 46-56.
Crossref
Crossref
J. Bobes, P. García-Portilla, P.A. Sáiz, T. Bascarán & M. Bousoño. (2020) Quality of life measures in schizophrenia. European Psychiatry 20:S3, pages S313-S317.
Crossref
Crossref
J. M. Haro, E. T. Edgell, D. Novick, J. Alonso, L. Kennedy, P. B. Jones, M. Ratcliffe & A. Breier. (2005) Effectiveness of antipsychotic treatment for schizophrenia: 6-month results of the Pan-European Schizophrenia Outpatient Health Outcomes (SOHO) study. Acta Psychiatrica Scandinavica 111:3, pages 220-231.
Crossref
Crossref